Retrophin announced it has signed an agreement with Novartis for an exclusive license for Syntocinon (oxytocin) Nasal Spray. Syntocinon Nasal Spray was initially approved in 1960 to assist initial ...
Oxytocin (Syntocinon) is a uterine stimulant, prescribed for the initiation of uterine contractions and induction of labor in women as well as stimulation of contractions in cases where the uterus ...
Oxytocin (Syntocinon®) and ergometrine with oxytocin (Syntometrine®) are two well-known brands of oxytocics in current use in maternity centres within the UK. It is common practice to refer to these ...
Oxytocin is a hormone best known for its roles in childbirth and lactation. Oxytocin is sometimes referred to as the “love hormone” or “love drug” for its roles in sexual bonding, parenting, and other ...
Retrophin is acquiring San Diego, CA-based firm Kyalin Biosciences, an early-stage company focused on therapies targeting the core symptoms of autism and related conditions. The deal is scheduled to ...
NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (OTCQB:RTRX) today announced that it has signed an agreement with Novartis Pharma AG for an exclusive U.S. license for Syntocinon™ Nasal Spray, the ...
The lack of national guidelines governing the use of a drug used to speed up labour is putting unborn children at “unnecessary risk”, says the Master of the Rotunda Hospital. Dr Sam Coulter Smith said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results